Login
$GENB
$10.60 +$0.11 (1.05%) After hours

Company Executives

Management Team

From Forms 3, 4 and 5 filed in the last 18 months
Officer Source
Michael Nally
Chief Executive Officer
Title from the Form 4 dated Mar 4, 2026
Jason Silvers
President & CFO
Title from the Form 4 dated Feb 26, 2026
Gevorg Grigoryan
Chief Technology Officer
Title from the Form 4 dated Feb 26, 2026
Sean Martin
Chief Legal Officer & GC
Title from the Form 4 dated Feb 26, 2026
Laurie Anne Lee
Chief Medical Officer
Title from the Form 4 dated Feb 26, 2026
Beth Grous
Chief People Officer
Title from the Form 4 dated Feb 26, 2026
Aarif Khakoo
Chief Scientific Officer
Title from the Form 3 dated Feb 26, 2026

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

No proxy statement on record

Board of Directors comes from the company’s proxy statement. Generate Biomedicines, Inc. has not filed one with the SEC.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. Generate Biomedicines, Inc. has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support